MDxHealth Grants QIAGEN Rights to MSP Technology

News   Jun 21, 2016

 
MDxHealth Grants QIAGEN Rights to MSP Technology
 
 
 

RELATED ARTICLES

Targeting Telomerase: A Therapeutic Strategy for Difficult-to-Treat Melanoma

News

Targeting telomerase was effective at killing NRAS-mutant melanoma cells, and the impact was further enhanced when the strategy was paired with an inhibitor of mitochondrial function, according to study results by The Wistar Institute published in Oncogene.

READ MORE

The Protein Lasso Implicated in Breast Cancer

News

Certain types of RNA are implicated in the production of pro-breast cancer proteins. Now, a new study has shed light on the mechanism by which these RNAs manipulate DNA to produce these proteins.

READ MORE

New Target for Immunotherapy for Solid Tumors?

News

Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE